Heron Therapeutics Inc (NAS:HRTX)
$ 3.465 0.045 (1.32%) Market Cap: 522.01 Mil Enterprise Value: 625.89 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 68/100

Heron Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 20, 2023 / 03:45PM GMT
Release Date Price: $2.55 (-5.56%)
Serge Belanger
Needham & Company - Analyst

Hi, good morning. I'm Serge Belanger, one of the senior healthcare analysts at Needham. Want to welcome you to our 22nd Annual Healthcare Conference.

And for our next session, we're happy to have with us the new CEO of Heron Therapeutics, Craig Collard. He's going to give us an overview of the company, then we'll jump to Q&A. For those listening in on the conference portal, you do have the option to submit questions. It should be at the bottom of the screen you're currently looking at.

So, Craig, I'll hand it over to you. I know it's only been a few weeks in the new seat, but looking forward to speaking with you about Heron today.

Craig Collard
Heron Therapeutics, Inc. - CEO

Okay. Thanks, Serge. I'll really just give a brief overview of the company. Again, I've been here two weeks and came into this fairly fast [activist] group that came into the company. I joined originally as a Board member and wasn't really anticipating jumping right into the CEO role, and that became available.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot